Bayer Czech Republic - Indebtedness

Net Debt/EBITDA & Net Debt/Equity
Pharmaceutical | Czech Republic | March 19, 2018
$2.99
Excel Sheet

Bayer Czech Republic's net debt reached CZK 150 mil and accounted for 0.608 of equity at the end of 2015. The ratio is up 585% when compared to the previous year.

Historically, the firm’s net debt to equity reached an all time high of 0.608 in 2015 and an all time low of -0.372 in 2008.

When compared to EBITDA, net debt amounted to 0.890x at the end of the year. The ratio reached an all time high of 9.61 in 2007 and an all time low of -1.03 in 2010.

As far as Bayer Czech Republic's peers are concerned, Roche Czech Republic posted net debt to equity of 0.557x and 3.15x when compared to EBITDA at the end of 2015. Amgen Czech Republic ended the year 2015 with a net debt at 0.387x of equity and 1.53x when compared to its EBITDA while Amgen Czech Republic had net debt at 0.387x of equity and 1.53x to EBITDA at the end of the year.

You can see all the company’s data at Bayer Czech Republic Profile, or you can download a report on the company in the report section.